Ignite Creation Date:
2024-05-06 @ 5:40 PM
Last Modification Date:
2024-10-26 @ 2:33 PM
Study NCT ID:
NCT05385705
Status:
RECRUITING
Last Update Posted:
2024-04-23
First Post:
2022-05-17
Brief Title:
A Study of Allogenic Natural Killer Cells in Combination With Trastuzumab and Pertuzumab in Adult Patients With Refractory Metastatic Her2 Positive Breast Cancer NK-ACT-BC_2020
Sponsor:
Vall dHebron Institute of Oncology
Organization:
Vall dHebron Institute of Oncology
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05-11
Start Date Type:
ACTUAL
Primary Completion Date:
2026-09-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-04-11
Completion Date Type:
ESTIMATED
First Submit Date:
2022-05-17
First Submit QC Date:
May 17 2022
Study First Post Date:
2022-05-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-22
Last Update Post Date:
2024-04-23
Last Update Post Date Type:
ACTUAL